TMCnet News
UCSF Rosenman ADAPT Seeks Healthtech Companies Addressing Health Disparities; Will Assist in Scaling Up SolutionsSAN FRANCISCO, Aug. 31, 2021 /PRNewswire/ -- Applications are now open for UCSF Rosenman ADAPT (ADAPT), a program that provides emerging health technology companies with funding and opportunities to partner with the largest healthcare companies in the United States, the UCSF Rosenman Institute (Rosenman) announced today. The deadline is 5 pm ET on Friday, October 1st. Anthem, Inc., Chicago Pacific Partners, Evernorth, and UnitedHealth Group, who together serve more than 200 million people in the U.S. healthcare market, have partnered with Rosenman to provide resources for accelerating market testing and commercialization. Four companies selected will receive $100K in non-dilutive funding apiece, and a match with one of the program's partners. Applications to ADAPT will be accepted from companies based anywhere in the world that have at least developed a minimum viable product. Of particular interest are technologies that address health disparities, especially for communities of color, and LGBTQ communities, and people who struggle to afford healthcare; improve health outcomes at the population/community level; and improve efficiency in healthcare. Rosenman encourages teams that are minority, LGBTQ+- and women-led to apply for the program. "Our goal is to get vital new solutions into the market where they can ensure that communities that have historically been underserved can access the healthcare they need," said Rosenman director Christine Winoto. "ADAPT is unique in being able to recruit such a wide range of technologies and broker connections between emerging companies and dominant players. It is an incredible opportunity for deserving entrepreneurs." "The UCSF Rosenman ADAPT program aligns with our goal to improve health in all its forms, challenge the status quo, and usher in a new era of healthcare that addresses the unique needs of diverse communities," said Omid Toloui, Vice President, Innovation, at Anthem. "We look forward to working with high-potential, early-stage companies to scale innovative solutions and increase access to high-quality healthcare services for all individuals, independent of their location or socioeconomic status." "As one of the very few women-led private equity firms in the US, we feel completely aligned with the mission of ADAPT on a number of levels," said Mary Tolan, Co-Founder and Managing Partner of Chicago Pacific Founders. "At our core our firm looks to expand access to the highest quality healthcare and bend the cost curve, all while promoting and encouraging diversity. We are excited at partnering with such an esteemed group as has been assembled here." "At Evernorth, we are committed to solving the toughest, most costly health care hallenges, and especially, health care disparities. Innovative solutions like the ones being developed by ADAPT applicants are core to our mission," said Glen Stettin, MD, Chief Innovation Officer at Evernorth. "We look forward to working with our second group of ADAPT program applicants and helping them advance innovations to combat health disparities." "Improving health equity and reducing health disparities are critically important to addressing health care's biggest challenges," said David Cook, MD, Chief Medical Officer, UnitedHealth Group's OptumLabs. "We can't wait to see the new technologies in 2021 and look forward to collaborating with these companies." To learn more about partnering with UCSF Rosenman ADAPT, contact [email protected]. About the UCSF Rosenman Institute About Anthem, Inc. About Chicago Pacific Founders About Evernorth About UnitedHealth Group
SOURCE UCSF Rosenman Institute ![]() |